Skymax Lifescience Profile
Key Indicators
- Authorised Capital ₹ 2.60 M
as on 17-07-2024
- Paid Up Capital ₹ 2.60 M
as on 17-07-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.26 Cr
as on 17-07-2024
- Satisfied Charges ₹ 1.56 Cr
as on 17-07-2024
- Revenue -8.14%
(FY 2023)
- Profit -41.32%
(FY 2023)
- Ebitda 2.76%
(FY 2023)
- Net Worth 9.41%
(FY 2023)
- Total Assets -7.40%
(FY 2023)
About Skymax Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.60 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹2.26 Cr. The company has closed loans amounting to ₹1.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pareshkumar Shah, Maulik Patel, Kirtikumar Meghani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233GJ2010PTC059242
- Company No.
059242
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Choryasi, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Skymax Lifescience Private Limited offer?
Skymax Lifescience Private Limited offers a wide range of products and services, including Aceclofenac Tablet, Aceclofenac Paracetamol Tablet, Antidepressant & Anti Anxiety Medicines, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Antifungal Cream, Ointment & Powder, Clobetasol Propionate Cream, Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Skymax Lifescience?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pareshkumar Shah  | Director | 07-Apr-2015 | Current |
| Maulik Patel | Director | 15-Feb-2012 | Current |
| Kirtikumar Meghani | Director | 14-Apr-2010 | Current |
| Pankaj Padmani | Director | 03-Dec-2014 | Current |
Financial Performance of Skymax Lifescience.
Skymax Lifescience Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.14% decrease. The company also saw a substantial fall in profitability, with a 41.32% decrease in profit. The company's net worth moved up by a moderate rise of 9.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skymax Lifescience?
In 2023, Skymax Lifescience had a promoter holding of 64.67% and a public holding of 35.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bluebubble East India Laundry Private LimitedActive 11 years 8 months
Pankaj Padmani is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 20 Oct 2023 | ₹0.50 M | Open |
Hdfc Bank Limited Creation Date: 21 Aug 2021 | ₹4.55 M | Open |
Hdfc Bank Limited Creation Date: 31 May 2021 | ₹0.40 M | Open |
How Many Employees Work at Skymax Lifescience?
Skymax Lifescience has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skymax Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skymax Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
